Patents by Inventor Pasquale Delli Bovi

Pasquale Delli Bovi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cctra gene as a tool to produce male-only progeny in the mediterranean fruitfly ceratitis capitata
    Publication number: 20040082032
    Abstract: This invention refers to the identification of the Cctra gene (SEQ.ID.NO. 1) and to corresponding dsRNA molecules comprising Cctra gene.sequences as a tool to produce only-male progeny in the Mediterranean fruitfly Ceratitis capitata.
    Type: Application
    Filed: September 8, 2003
    Publication date: April 29, 2004
    Inventors: Pasquale Delli Bovi, Attilio Pane, Catello Polito, Giuseppe Saccone
  • Mammalian growth factor
    Patent number: 6680297
    Abstract: A mammalian growth factor, displaying homology to both basic and acidic fibroblast growth factor in a single polypeptide chain, is disclosed herein. The growth factor was isolated from cells transfected with the DNA extracted from Kaposi's Sarcoma cells.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: January 20, 2004
    Assignee: New York University
    Inventors: Claudio Basilico, Pasquale Delli Bovi
  • Mammalian growth factor
    Publication number: 20030004319
    Abstract: A mammalian growth factor, displaying homology to both basic and acidic fibroblast growth factor in a single polypeptide chain, is disclosed herein. The growth factor was isolated from cells transfected with the DNA extracted from Kaposi's Sarcoma cells.
    Type: Application
    Filed: August 27, 2001
    Publication date: January 2, 2003
    Applicant: New York University
    Inventors: Claudio Basilico, Pasquale Delli Bovi
  • Mammalian growth factor nucleic acids, vectors, and host cells
    Patent number: 6432702
    Abstract: A truncated mammalian growth factor, displaying homology to both basic and acidic fibroblast growth factor in a single polypeptide, is disclosed herein. The growth factor is substantially smaller (i.e. has fewer amino acid residues) than the full-length mammalian growth factor, has a higher affinity for fibroblast growth factor receptors than full-length K-FGF and basic fibroblast growth factor and increased mitogenic activity. Also disclosed herein are DNA sequences encoding the truncated growth factor, pharmaceutical formulations containing the truncated growth factor and methods to heal burns and wounds in a mammal by administering the pharmaceutical formulations.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 13, 2002
    Assignee: New York University
    Inventors: Claudio Basilico, Pasquale Delli Bovi
  • Mammalian growth factor
    Patent number: 6355781
    Abstract: A homogeneous K-FGF polypeptide having a molecular weight of about 19,000 daltons when analyzed by SDS polyacrylamide gel electrophoresis, wherein the polypeptide is substantially free of oligosaccharide moieties attached to the polypeptide, appears as a single band on SDS-PAGE, exhibits a detectable level of mitogenic activity on growth arrested cells in a 3H-thymidine uptake assay, and is substantially free from other mammalian proteins, is provided.
    Type: Grant
    Filed: December 31, 1996
    Date of Patent: March 12, 2002
    Assignee: New York University
    Inventors: Claudio Basilico, Pasquale Delli Bovi
  • Mammalian growth factor
    Patent number: 5750659
    Abstract: A mammalian growth factor, displaying homology to both basic and acidic fibroblast growth factor in a single polypeptide chain, is disclosed herein. The growth factor was isolated from cells transfected with the DNA extracted from Kaposi's Sarcoma cells.
    Type: Grant
    Filed: May 3, 1993
    Date of Patent: May 12, 1998
    Assignee: New York University
    Inventors: Claudio Basilico, Pasquale Delli Bovi